Rxsight Inc (RXST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 34,887 | 29,512 | 28,579 | 22,199 | 20,810 |
| Cost of Goods | 10,637 | 8,827 | 10,926 | 8,468 | 8,795 |
| Gross Profit | 24,250 | 20,685 | 17,653 | 13,731 | 12,015 |
| Operating Expenses | 33,220 | 32,182 | 29,430 | 26,711 | 26,435 |
| Operating Income | -8,333 | -10,670 | -10,851 | -12,512 | -13,625 |
| Interest Expense | 6 | 6 | 3 | 230 | 1,568 |
| Other Income | 2,276 | 1,585 | 1,659 | 339 | 1,415 |
| Pre-tax Income | -6,063 | -9,091 | -9,195 | -12,403 | -13,778 |
| Income Tax | 16 | 9 | -18 | 12 | 26 |
| Net Income Continuous | -6,079 | -9,100 | -9,177 | -12,415 | -13,804 |
| Net Income | $-6,079 | $-9,100 | $-9,177 | $-12,415 | $-13,804 |
| EPS Basic Total Ops | -0.16 | -0.25 | -0.24 | -0.35 | -0.40 |
| EPS Basic Continuous Ops | -0.16 | -0.25 | -0.24 | -0.35 | -0.40 |
| EPS Diluted Total Ops | -0.16 | -0.25 | -0.24 | -0.35 | -0.40 |
| EPS Diluted Continuous Ops | -0.16 | -0.25 | -0.24 | -0.35 | -0.40 |
| EPS Diluted Before Non-Recurring Items | -0.16 | -0.25 | -0.26 | N/A | N/A |
| EBITDA(a) | $-9,586 | $-11,035 | $-11,344 | $-12,970 | $-14,149 |